Skip to main content
Dryad

PTPN2 negatively regulates macrophage immune responses and cellular bioenergetics

Vinette, Valerie1; Zolotarov, Yevgen2; Poirier, Alexandre2; Cordova, Zuzet2; Aubry, Isabelle2; Tremblay, Michel2

Published Apr 21, 2026 on Dryad. https://doi.org/10.5061/dryad.7h44j1040

Data files

Apr 21, 2026 version files 26.97 GB

Click names to download individual files Select up to 11 GB of files for zip download

Abstract

PTPN2 is encoded by the protein tyrosine phosphatase N2 (also known as TC-PTP) and is a negative regulator of cytokine signaling and macrophage differentiation. In the past decade, our work and others', including several pharmaceuticals, have emphasized that inhibition of PTPN2 and PTPN1 (also known as PTP1B) may act as a new first-of-class cancer immunotherapeutic. Although the potential roles of these two enzymes in various immune cells have been broadly reported, the specific activity of PTPN2 in regulating macrophage immune and metabolic responses has yet to be fully elucidated. Hence, we sought to investigate the specific role of PTPN2 in macrophage polarization and function. We used two different mouse models to systematically and specifically inhibit the expression of PTPN2 in macrophages and utilized a chemical inhibitor with a macrophage human cell line to assess their immune and metabolic profiles. We demonstrated that PTPN2 ablation in macrophages alters their immunometabolic transcriptome and enhances their pro-inflammatory response, as observed by increased IFN-ɣ and nitric oxide production. PTPN2 deficiency also leads to a dysregulation of mitochondrial respiration, as observed by decreased oxygen consumption and ATP production. We establish herein that PTPN2 dampens the pro-inflammatory response of macrophages while altering their mitochondrial respiration, validating its macrophage inhibition as a contributing factor in the potency of systemic dual inhibition of PTPN1 and PTPN2 against cancer.